<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 21, 1998
CHOLESTECH CORPORATION
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
California 000-20198 94-3065493
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification
incorporation) No.)
</TABLE>
3347 Investment Boulevard
Hayward, California 94545
(Address of principal executive offices)
(510) 732-7200
(Registrant's telephone number, including area code)
<PAGE> 2
ITEM 5. OTHER EVENTS
On May 21, 1998, Cholestech Corporation issued a press release reporting
that it has settled outstanding litigation with a former employee of the
Company. The text of the press release is attached to this Report as Exhibit
99.1.
-1-
<PAGE> 3
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits:
99.1 Press Release dated May 21, 1998.
-2-
<PAGE> 4
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CHOLESTECH CORPORATION
Dated: May 27, 1998 By: /s/ Andrea J. Tiller
--------------------
Andrea J. Tiller
Vice President, Finance and
Chief Financial Officer
-3-
<PAGE> 5
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT NO. DESCRIPTION
- ----------- -----------
<S> <C>
99.1 Press Release dated May 21, 1998.
</TABLE>
-4-
<PAGE> 1
CHOLESTECH
(BW) (CHOLESTECH) (CTEC) Cholestech Announces Settlement
Business Editors
HAYWARD, Calif. -- (BUSINESS WIRE) -- May 21, 1998 -- Cholestech
Corporation (NASDAQ:CTEC) today announced it has settled outstanding litigation
with a former employee of the Company.
The financial impact to Cholestech is a one-time, non-recurring
charge of approximately $250,000, or $(0.02) per share (diluted), which will be
realized in the quarter ending June 26, 1998.
Statements contained in this press release regarding the
Company's future operating results, including potential impacts on earnings, are
forward-looking statements, the accuracy of which are necessarily subject to
risks and uncertainties. Actual results may be affected by factors set forth in
the Company's Securities and Exchange Commission filings including the Company's
Form 10-K for the year ended March 27, 1998 and the Company's registration
statement on Form S-3 filed April 29, 1998.
Contact:
Andrea J. Tiller
Vice President, Finance and Chief Financial Officer
Cholestech Corporation
3347 Investment Blvd.
Hayward, CA 94545-3808
510/732-7200
[email protected]
CHOLESTECH CORPORATION
3347 INVESTMENT BOULEVARD
HAYWARD, CA 94545-3808
(510) 732-7200 FAX (510) 732-7227
